MedPath

Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements

Completed
Conditions
Corneal Endothelial Cell Loss
Interventions
Device: Topcon Specular Microscope SP-1P
Device: Konan Specular Microscope CELLCHEK XL
Registration Number
NCT02138266
Lead Sponsor
Topcon Medical Systems, Inc.
Brief Summary

The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-Pathologic Adults age 18-28 yrsTopcon Specular Microscope SP-1PNon-Pathologic Adults age 18-28 yrs
Non-Pathologic Adults age 18-28 yrsKonan Specular Microscope CELLCHEK XLNon-Pathologic Adults age 18-28 yrs
Non-Pathologic Adults age 29-80 yrsKonan Specular Microscope CELLCHEK XLNon-Pathologic Adults age 29-80 yrs
Non-Pathologic Adults age 29-80 yrsTopcon Specular Microscope SP-1PNon-Pathologic Adults age 29-80 yrs
Pathologic Adults age 29-80 yrsTopcon Specular Microscope SP-1PPathologic Adults age 29-80 yrs
Pathologic Adults age 29-80 yrsKonan Specular Microscope CELLCHEK XLPathologic Adults age 29-80 yrs
Primary Outcome Measures
NameTimeMethod
Central corneal thicknessSingle time point - 1 day
Coefficient of variation of endothelial cell areaSingle time point - 1 day
Corneal endothelial cell densitySingle time point - 1 day
Corneal endothelial cell % hexagonalitySingle time point - 1 day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Andover Eye Associates

🇺🇸

Andover, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath